Patients with inflammatory bowel disease (IBD) or primary sclerosing cholangitis (PSC) show promising outcomes when receiving advanced therapies following liver transplantation, according to study ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ORLANDO -- Vedolizumab (Entyvio) and infliximab ...

A remarkable development in breast cancer research has revealed a fundamental mechanism behind driving cancer invasion and ...

免疫性炎症是由于免疫系统异常反应并攻击正常组织而引起的炎症。这种炎症反应并非由外部病原体（如细菌、病毒等）直接引起，而是由于免疫系统的错误激活导致了自身组织的损伤。常见的免疫性炎症反应包括自身免疫性肝炎、系统性红斑狼疮、类风湿关节炎、溃疡性结肠炎等。

It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a ...

Fmr LLC raised its position in shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) by 33.0% in the ...

The anti-TL1A antibody allowed significantly more inflammatory bowel disease (IBD) patients to go into remission than those ...

This Review highlights the roles of integrins and integrin-binding proteins in the control of kidney-cell morphology and functions as well as their role in kidney diseases Lo et al. implanted ...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced preliminary clinical data for the triplet combination of avutometinib and ...

However, our understanding of how gradual changes in gene dosage affect molecular, cellular, and organismal traits is currently limited. To address this gap, we induced gradual changes in gene ...